predictive-oncology.com (POAI) - Year-over-year earnings per share growth for the last twelve months
Predictive Oncology (POAI) management is successfully integrating AI into preclinical testing, strengthening ties with pharmaceutical companies. The business relies on external sample providers and AWS cloud services. However, geopolitical barriers to data exchange are hindering expansion. The relative growth of quarterly EPS visualizes these contradictions, where -1372.90 characterizes this valuation parameter, helping to filter out market noise and identify real profit dynamics.
POAI (Predictive Oncology): analytical breakdowns and indicator data
- market value and analyst target forecast:
- market capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Equity Ratio Predictive Oncology|POAI - Long-Term Debt to Capital|Short-Term Debt to Equity predictive-oncology.com|POAI - Company Total Debt|Debts to Book Capitalization Predictive Oncology Corp|POAI - Long-Term Debt|Company Short-Term Debt Predictive Oncology|Quick Liquidity Indicator predictive-oncology.com
- earnings and valuation multiples information:
POAI - Profit After Payment of Taxes|Expected Profit Predictive Oncology|POAI - Business Payback Period|Future Price to Earnings predictive-oncology.com|POAI - Market Cap to Earnings and Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Predictive Oncology Corp|POAI - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Predictive Oncology|POAI - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth predictive-oncology.com|POAI - Earnings per share growth this year|Earnings growth forecast for next year Predictive Oncology
Basic company analysis:Predictive Oncology Inc - POAI
The long-term sustainability of Predictive Oncology (POAI) is confirmed by its ability to generate profit even during market downturns, as measured by the quarterly EPS growth rate through earnings per share dynamics. The positive trend on this chart indicates business scalability, which for Predictive Oncology (POAI) directly depends on the commercialization of AI solutions for discovering new anti-cancer drugs in collaboration with pharma behemoths.
Analysis of competing companies
Intuitive (ISRG) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months DHR|Year-over-year earnings per share growth for the last twelve months Becton, Dickinson and Company|STERIS Group (STE) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months WST (West Pharmaceutical Services)|Year-over-year earnings per share growth rate for the last twelve months BAX|Year-over-year earnings per share growth for the last twelve months Masimo MASI|Year-over-year earnings per one share growth for the last 12 months STVN|TFX: Year-over-year net earnings per share growth for the last 12 months|MMSI - Quarterly EPS earnings growth|Envista Holdings (NVST) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months icumed.com|XRAY (Dentsply Sirona) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months LeMaitre Vascular Inc LMAT|Year-over-year earnings per share growth for the last twelve months AtriCure Corp (ATRC)|STAAR Surgical Co - Year-over-year earnings per share growth for the last 12 months|Chromadex Corp - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ZIMV (zimvie.com)|ANGO - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Cerus Corp. CERS|Alpha Teknova Inc (TKNO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months MGRM (Monogram Orthopedics Inc.)|Year-over-year earnings per share growth for the last twelve months Sharps Technology Inc|INFU: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth UTMD|KRMD - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth NYXH (Nyxoah, S.A.)|MBOT: Year-over-year earnings per share growth for the last 12 months|Pro-Dex, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months zentek.com ZTEK|ELUT: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Milestone Scientific Inc|Year-over-year net earnings per share growth for the last 12 months NXGL|RVP (Retractable Tech) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth HBIO|Year-over-year net earnings per share change for the last twelve months femasys.com|Meihua Medical Technologies Co., Ltd. - Year-over-year net earnings per share growth for the last 12 months|Callan JMB Inc. - Year-over-year earnings per share growth for the last twelve months|Atrion Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NeuroMetrix Corporation
